Jianerkang Medical Co.,Ltd. (SHA:603205)
China flag China · Delayed Price · Currency is CNY
20.63
-0.13 (-0.63%)
At close: Nov 17, 2026

Jianerkang Medical Cash Flow Statement

Millions CNY. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
123.45111.44120.22123.55157.34131.63
Depreciation & Amortization
47.647.642.6740.9536.8432.41
Other Amortization
3.083.082.171.621.551.52
Loss (Gain) From Sale of Assets
-0.56-0.56-0.43-0.033.02-0.13
Asset Writedown & Restructuring Costs
0.130.130.070.070.070.12
Loss (Gain) From Sale of Investments
-1.54-1.54-0.7416.19-0.1-0.35
Provision & Write-off of Bad Debts
-0.42-0.42-0.485.9514.55-5.5
Other Operating Activities
30.6114.143.780.98-3.297.29
Change in Accounts Receivable
-38.3-38.314.95-36.93-83.11-2.32
Change in Inventory
-1.16-1.16-25.197.31-17.259.65
Change in Accounts Payable
21.2221.22-21.68-0.946.08-107.28
Change in Other Net Operating Assets
5.685.684.8-2.656.135.52
Operating Cash Flow
187.28158.79141.1157.8163.0170.6
Operating Cash Flow Growth
34.98%12.54%-10.59%-3.20%130.90%-86.25%

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-100.51-69.98-39.75-84.18-66.32-48.64
Sale of Property, Plant & Equipment
2.22.662.980.150.210.19
Sale (Purchase) of Real Estate
---16.3--
Other Investing Activities
-249.390.890.26-16.190.10.41
Investing Cash Flow
-347.69-66.43-36.51-83.92-66.01-48.04

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Short-Term Debt Issued
----12050
Total Debt Issued
----12050
Short-Term Debt Repaid
----30-140-69.47
Long-Term Debt Repaid
--3.05----
Lease Payments
-3.05-3.05----
Total Debt Repaid
-3.05-3.05--30-140-69.47
Net Debt Issued (Repaid)
-3.05-3.05--30-20-19.47
Issuance of Common Stock
--412.55--3
Common Dividends Paid
-39-42.12--0.69-1.66-2.1
Other Financing Activities
-1.89-2.33-25.1-2-2.9-
Financing Cash Flow
-43.94-47.49387.45-32.69-24.57-18.57

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
-9.66-2.523.534.9210.35-2.56
Net Cash Flow
-214.0242.34495.5746.1182.791.42

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
86.7788.81101.3573.6296.721.96
Free Cash Flow Growth
8.32%-12.38%37.66%-23.86%340.34%-94.07%
Free Cash Flow Margin
7.90%8.67%9.69%7.12%8.85%2.81%
Free Cash Flow Per Share
0.560.570.820.630.830.19
Levered Free Cash Flow
63.755.4255.4512.3532.97-46.43
Unlevered Free Cash Flow
64.6456.1455.4512.7634-45.13
Free Cash Flow After Leases
83.7285.76101.3573.6296.721.96

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Income Tax Paid
--47.75-37.42-48.17--
Change in Working Capital
-15.08-15.08-26.15-31.47-46.97-96.39